Preeti Patel

Scopus Author ID ORCID

Publication Activity (10 Years)

Years Active: 2020-2024
Publications (10 Years): 25

Top Topics

Histone Deacetylase

Epidermal Growth Factor Receptor

Top Venues

Chemistry & biodiversity

Assay and drug development technologies

Journal of drug targeting

Anti-cancer agents in medicinal chemistry

This page only lists publications with an associated author ORCID identifier.

Publications

S Vishakha, N Navneesh, Balak Das Kurmi, Ghanshyam Das Gupta, Sant Kumar Verma, Ankit Jain, Preeti Patel
An Expedition on Synthetic Methodology of FDA-approved Anticancer Drugs (2018-2021). Anti-cancer agents in medicinal chemistry 24 (8) (2024)
Anjali Bisht, Shuvadip Bhowmik, Preeti Patel, Ghanshyam Das Gupta, Balak Das Kurmi
Aptamer as a targeted approach towards treatment of breast cancer. Journal of drug targeting 32 (5) (2024)
Shivani Kasana, Vaibhav Nigam, Surbhi Singh, Balak Das Kurmi, Preeti Patel
A New Insight Into The Huisgen Reaction: Heterogeneous Copper Catalyzed Azide-Alkyne Cycloaddition for the Synthesis of 1,4-Disubstituted Triazole (From 2018-2023). Chemistry & biodiversity (2024)
Shivani Kasana, Vaibhav Nigam, Surbhi Singh, Balak Das Kurmi, Preeti Patel
A New Insight Into The Huisgen Reaction: Heterogeneous Copper Catalyzed Azide-Alkyne Cycloaddition for the Synthesis of 1,4-Disubstituted Triazole (From 2018-2023). Chemistry & biodiversity 21 (6) (2024)
Sourabh Satapathy, Shivam Kumar, Balak Das Kurmi, Ghanshyam Das Gupta, Preeti Patel
Expanding the Role of Chiral Drugs and Chiral Nanomaterials as a Potential Therapeutic Tool. Chirality 36 (7) (2024)
Shivani Kasana, Vaibhav Nigam, Surbhi Singh, Balak Das Kurmi, Preeti Patel
A New Insight Into The Huisgen Reaction: Heterogeneous Copper Catalyzed Azide-Alkyne Cycloaddition for the Synthesis of 1,4-Disubstituted Triazole (From 2018-2023). Chemistry & biodiversity 21 (6) (2024)
Anjali Bisht, Shuvadip Bhowmik, Preeti Patel, Ghanshyam Das Gupta, Balak Das Kurmi
Aptamer as a targeted approach towards treatment of breast cancer. Journal of drug targeting (2024)
Vishakha S, Navneesh N, Balak Das Kurmi, Ghanshyam Das Gupta, Sant Kumar Verma, Ankit Jain, Preeti Patel
An Expedition on Synthetic Methodology of FDA-approved Anticancer Drugs (2018-2021). Anti-cancer agents in medicinal chemistry (2024)
Shivani Kasana, Vaibhav Nigam, Surbhi Singh, Balak Das Kurmi, Preeti Patel
A New Insight Into The Huisgen Reaction: Heterogeneous Copper Catalyzed Azide-Alkyne Cycloaddition for the Synthesis of 1,4-Disubstituted Triazole (From 2018-2023). Chemistry & biodiversity 21 (6) (2024)
Anjali Bisht, Shuvadip Bhowmik, Preeti Patel, Ghanshyam Das Gupta, Balak Das Kurmi
Aptamer as a targeted approach towards treatment of breast cancer. Journal of drug targeting 32 (5) (2024)
Pallavi Sandal, Preeti Patel, Dilpreet Singh, Ghanshyam Das Gupta, Balak Das Kurmi
α-Tocopherol Polyethylene Glycol 1000 Succinate-Based Cationic Liposome for the Intracellular Delivery of Doxorubicin in MDA-MB-231 Triple-Negative Breast Cancer Cell Line. Assay and drug development technologies (2023)
Pallavi Sandal, Lakshmi Kumari, Preeti Patel, Dilpreet Singh, Dilpreet Singh, Ghanshyam Das Gupta, Balak Das Kurmi
Doxorubicin Conjugates: An Efficient Approach for Enhanced Therapeutic Efficacy with Reduced Side Effects. Assay and drug development technologies (2023)
Pallavi Sandal, Lakshmi Kumari, Preeti Patel, Dilpreet Singh, Dilpreet Singh, Ghanshyam Das Gupta, Balak Das Kurmi
Doxorubicin Conjugates: An Efficient Approach for Enhanced Therapeutic Efficacy with Reduced Side Effects. Assay and drug development technologies (2023)
Shivanshu Pandey, Sitanshu Mondal, Kumari Kajal, Balak Das Kurmi, Sant Kumar Verma, Preeti Patel
Current progress in the targeted therapy of breast cancer: Structure-activity correlation and docking studies (2015-2021). Archiv der Pharmazie (2023)
Balak Das Kurmi, Preeti Patel, Rishi Paliwal, Pramod Kumar, Shivani Rai Paliwal
Multifunctional nanotherapeutics for intracellular trafficking of doxorubicin against breast cancer. Nanomedicine (London, England) (2023)
Vishakha S, Kumari Kajal, Sitanshu Mondal, Simranpreet K Wahan, Balak Das Kurmi, Ghanshyam Das Gupta, Preeti Patel
Novel VEGFR-2 Kinase Inhibitors as Anticancer Agents: A Review Focusing on SAR and Molecular Docking Studies (2016-2021). Chemistry & biodiversity 20 (2) (2023)
Pallavi Sandal, Lakshmi Kumari, Preeti Patel, Dilpreet Singh, Dilpreet Singh, Ghanshyam Das Gupta, Balak Das Kurmi
Doxorubicin Conjugates: An Efficient Approach for Enhanced Therapeutic Efficacy with Reduced Side Effects. Assay and drug development technologies (2023)
Pallavi Sandal, Lakshmi Kumari, Preeti Patel, Dilpreet Singh, Dilpreet Singh, Ghanshyam Das Gupta, Balak Das Kurmi
Doxorubicin Conjugates: An Efficient Approach for Enhanced Therapeutic Efficacy with Reduced Side Effects. Assay and drug development technologies (2023)
Vishakha S, Kumari Kajal, Sitanshu Mondal, Simranpreet K Wahan, Balak Das Kurmi, Ghanshyam Das Gupta, Preeti Patel
Novel VEGFR-2 Kinase Inhibitors as Anticancer Agents: A Review Focusing on SAR and Molecular Docking Studies (2016-2021). Chemistry & biodiversity 20 (2) (2023)
Kanak Chahar, Yash Sharma, Preeti Patel, Vivek Asati, Balak Das Kurmi
A mini-review on recent strategies and applications of nanomedicines to combat Antimicrobial Resistance. Current drug metabolism (2023)
Vishakha S, Kumari Kajal, Sitanshu Mondal, Simranpreet K Wahan, Balak Das Kurmi, Ghanshyam Das Gupta, Preeti Patel
Novel VEGFR-2 Kinase Inhibitors as Anticancer Agents: A Review Focusing on SAR and Molecular Docking Studies (2016-2021). Chemistry & biodiversity 20 (2) (2023)
Vishakha S, Kumari Kajal, Sitanshu Mondal, Simranpreet K Wahan, Balak Das Kurmi, Ghanshyam Das Gupta, Preeti Patel
Novel VEGFR-2 Kinase Inhibitors as Anticancer Agents: A Review Focusing on SAR and Molecular Docking Studies (2016-2021). Chemistry & biodiversity (2023)
Mritunjay Kumar, Yash Sharma, Kanak Chahar, Lakshmi Kumari, Lopamudra Mishra, Preeti Patel, Dilpreet Singh, Balak Das Kurmi
Validation of a Novel Supercritical Fluid Extractor/Dryer Combo Instrument. Assay and drug development technologies (2023)
Lopamudra Mishra, Shuvadip Bhowmik, Rajveer Singh, Preeti Patel, Ghanshyam Das Gupta, Balak Das Kurmi
Quality by design-assisted development of D-α-tocopherol polyethylene glycol 1000 succinate-incorporated gefitinib-loaded cationic liposome(s). Therapeutic delivery (2023)
Ekta Shirbhate, Preeti Patel, Vijay K Patel, Ravichandran Veerasamy, Prabodh Chander Sharma, Harish Rajak
The combination of histone deacetylase inhibitors and radiotherapy: a promising novel approach for cancer treatment. Future oncology (London, England) 16 (30) (2020)